ADAM17 and renal cell carcinoma: Another study examining the relationship between ADAM17 and Notch signaling showed that ADAM17 is a key enzyme for activation of the Notch signaling pathway, and that inhibition of its activity effectively promotes apoptosis and impairs invasion ability in renal cell carcinoma [49].